Introduction
Human immunodeficiency type-1 (HIV-1) mother-to-child transmission (MTCT) has been dramatically reduced with the introduction of HIV test in all pregnant women and consequent antiretroviral drugs administration in those positive for virus infection; also alternative to breastfeeding and caesarean partum contributed to prevent MTCT [1] . Nevertheless, data from past years in which antiretroviral drugs were not yet available for prevention provide a unique model to understand the role of host genetic factors in the modulation of HIV-1 infection susceptibility, a multifactorial trait [2] .
So far several genes and genetic polymorphisms (e.g. single nucleotide polymorphisms, SNPs) have been described as conferring risk or protection towards HIV-1 infection [3] . Since innate immunity is known to play a crucial role in the immune system of the foetus, we focused our attention on functional genetic variations distributed in primary natural defence genes. Therefore, we studied DEFB1 (8p23.1) gene encoding for the human beta defensins 1 (hBD-1), an antimicrobial peptide [4] , known for its antimicrobial properties against bacteria, fungi but also viruses [5] and already investigated in the context of HIV-1 MTCT [6, 7, 8, 9] . DEFB1 expression has been detected in the placenta, and a role in the protection against HIV-1 mother-to-foetus transmission has been hypothesized [9] . DEFB1 gene presents different functional polymorphisms, the -52G>A (rs1799946), -44C>G (rs1800972) and -20G>A (rs11362) at the 5' untranslated region (5'UTR) and c.*87A>G (rs1800971) at the 3'UTR possibly modulating DEFB1 gene expression in different cellular models [10, 11, 12, 13] .
In this study, taking into account the previously reported role of DEFB1 genetic variations in the context of HIV-1 infection, we analysed the four above-mentioned 
Material and Methods

Study population
The Zambia Exclusive Breastfeeding Study (ZEBS, Lusaka Zambia, ClinicalTrials.gov Identifier: NCT00310726) population recruited for this study was previously analysed in another work by Segat et al. [14] : briefly the ZEBS was a randomized clinical trial that investigated if exclusive breastfeeding up to 4 months could reduce the risk of HIV-1 transmission respect to longer breastfeeding through a median of 16 months. Nine hundred and fifty-eight HIV-1 positive women were enrolled during pregnancy at two prenatal care clinics (May 2001 to September 2004), and they were followed to delivery and 24 months post partum with their infants who were tested regularly for HIV. All women were counseled to breastfeed to at least 4 months, then, half of the women were randomized to stop all breastfeeding and the other half to continue breastfeeding for as long as they usually would. Detailed information is provided in table supplementary 1.
For the current genetic analysis 331 infants were selected: 85 were HIV-1 infected 
DEFB1 genotyping
DNA extraction was performed from dried blood spots as described in Segat et al. [14] . The four polymorphisms at DEFB1 gene were detected using TaqMan (rs1800971) polymorphisms using respectively C__11636795_20, C__11636794_10, C__11636793_20 and C___8845559_10 assays.
J U S T A C C E P T E D
Statistical analysis
DEFB1allele and genotype frequencies were calculated by direct counting, while haplotype frequencies and linkage disequilibrium were computed using the Arlequin software version 3.5.1.2 [15] .
Nonparametric Wilcoxon rank sum test with continuity correction were used to compare continuous variables. Fisher's exact test was used for pairwise comparison of allele, genotype and haplotype frequencies. Logistic regression and Wald's test were conducted to examine the association between polymorphisms genotypes and the risk of HIV-1 MTCT. The statistical tests were performed with the free software R version 3.1.3 [16] . P-value for linkage disequilibrium analysis was calculated using the permutation test with the EM algorithm, on Arlequin [15] , whereas D' and r 2 measures were computed with SNPstat [17] . Post-hoc power calculations were performed with G*Power software version 3.1.9.2 using post-hoc calculation using
Fisher's exact test [18] . (table 1, 2 and   supplementary table 2 ). The polymorphisms were in linkage disequilibrium in the children but not in the mothers (D'>0.51, r 2 >0.01, p<0.04 and D'>0.645, r 2 >0.02, p<0.07 respectively) and combined to form three major haplotypes, namely ACGA, GCAA, ACGG and other minor haplotypes (with frequency <0.05).
Results
HIV
Analysing DEFB1 polymorphisms' allele and genotype frequency distribution no statistical significant differences were observed between HIV+ and HIV-children, also when stratifying for HIV-1 routes of MTCT (table 1, table 2 3 ; plasma viral load cut off=50000 copies/ml; mothers group (n=101): low=399-48180 copies/ml, high=50800-75001 copies/ml; children's mothers (n=331): low=399-49748 copies/ ml, high=50291-75001 copies/ml. DEFB1polymorphisms frequencies were not significantly different comparing HIV+ and HIV-children and also between TR and NTR mothers (table supplementary 3 and 4 respectively).
Discussion
In our study we tested the possible association between functional variations at Another study investigated the role of the 5'UTR DEFB1 polymorphisms in seropositive mother and their infants comparing them with healthy women and their newborns in a population from a Colombia, but no statistically significant different polymorphism frequencies were observed between the two groups [9] .
The differences between our findings respect to the previous studies cited above could be explained based upon the different ethnic origin of the population analysed, and considering the fact that in some studies the comparison has been conducted between healthy subjects and HIV-1 infected individuals and not between exposed un-infected and infected subjects; furthermore only our study considered the virus route of transmission, while the others just reported general susceptibility to HIV-1 MTCT. Instead, for the 3'UTR c.*87A>G polymorphism this was the first study that considered this genetic variant in the context of HIV-1 infection and reported its association with the risk of MTCT.
Beta defensins are important mediators of innate mucosal defence against microbial infection and are also known for their antiviral activities [22] . There are controversial reports regarding DEFB1 expression in various fluid tissues or cell lines [11, 12, 23, 24 , 25], nevertheless hBD-1 is constitutively expressed at the mucosa surface [22] and, very important for HIV-1 MTCT, in the placenta [9] . On the other hand, recent evidences suggested that hBD-1 could be also induced by virus infection in vitro and in vivo [26] , and also in conventional monocytes from HIV-1 infected patients in the acute phase but not in the chronic stage [27] Our study indicated that the four DEFB1 polymorphisms could be involved in the HIV-1 infection susceptibility, suggesting also an additive and cooperative effect: it is possible to speculate that the DEFB1 c. We are aware of a limitation of our study since the lack of biological samples other than dried blood spots used for DNA extraction, didn't allow us to quantify hBD-1 protein to validate our hypothesis.
In our study DEFB1 polymorphisms were not correlated with maternal viral load or CD4 cells count, however former works evidenced that -52 G/G genotype was correlated with low levels of HIV-1 RNA in breast milk of Mozambican women [29] .
Moreover, -52 G/G genotype and -44C/G genotype were associated with low plasma HIV-1 RNA in Italian women [6] . The difference could be due to different states of disease progression not specified in these studies. 
